Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2007 (Vol. 27, No. 1)

NEBcutter

URL:tools.neb.com/nebcutter2/index.php
  • Useful free resource
  • None
Here’s a first. I got a letter from a Nobel Laureate who reads the column suggesting that I review this site. It turned out to be a good one, so I decided to cover it for “Best of the Web.” NEBcutter has been out there for quite a while, and though I’ve mentioned it in passing before, I’ve never written it up. What NEBcutter does is identify open reading frames and restriction enzyme sites (with a few interesting wrinkles) within DNAs of up to 1 million bp in length. Hosted by New England Biolabs, the site offers numerous options, including open reading frame selections, plus quite a few different enzyme sets for the picking. It’s free, it’s fast, and it will provide anyone needing simple DNA sequence analysis with tools they can use. Definitely worth a bookmark.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »